HDAC9 and urinary bladder cancer: The HDAC-inhibitor sodium butyrate has been shown to induce apoptosis in the bladder cancer cell lines, T24 and 5637, by increasing ROS production via activation of AMP-activated protein kinase (AMPK) and inactivation of the mechanistic target of rapamycin (mTOR) pathway [58].